Myeloablative Versus Reduced-Intensity Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic SyndromesBart L. Scott, Mitchell E. Horwitz, Steven M. Devine et al.|Journal of Clinical Oncology|2017Cited by 664
Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis After Mismatched Unrelated Donor Peripheral Blood Stem Cell TransplantationMonzr M. Al Malki, Antonio Jiménez, Stephanie Bo‐Subait et al.|Journal of Clinical Oncology|2025Cited by 23